| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-20 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.33 | 8e-16 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-14 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.27 | 9e-09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |